Navigation Links
PLC Medical Systems Adds Vice President of Clinical Affairs
Date:5/18/2011

FRANKLIN, Mass., May 18, 2011 /PRNewswire/ -- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that it has named Susan Papalia, RN, BSN, Vice President of Clinical Affairs.  In her new role, she will be responsible for overseeing and leading the U.S. clinical study of the company's innovative product, RenalGuard®.  RenalGuard has already obtained the CE Mark in the European Union, and PLC plans to commence the pivotal trial in the U.S. to seek approval for sales and marketing from the U.S. Food & Drug Administration.

Said Mark R. Tauscher, President and Chief Executive Officer, "Susan brings to PLC more than 20 years of experience in clinical research and regulatory approvals related to the launch of new medical devices in the U.S. and international markets.  With her expertise and our innovative technology, we are looking forward to the first subject enrollments in the U.S. pivotal trial for RenalGuard.  We are confident that the results will confirm the effectiveness of RenalGuard and the associated RenalGuard Therapy® in reducing the incidence of Contrast-Induced Nephropathy (CIN) in at-risk patients, as already demonstrated in the results from the investigator-sponsored REMEDIAL II and MYTHOS clinical trials in Italy."

Ms. Papalia joins PLC Medical Systems from Correx, Inc., where she was VP of Clinical Affairs and played a key role in the launch of the Correx Aortic Valve Bypass (AVB) kit in the EU and Canada.  Prior to that, she held a series of senior clinical affairs positions at both Boston Scientific Corporation and Mitralign, Inc. and clinical research positions in cardiology at the New England Medical Center and St. Elizabeth's Hospital in Boston, MA. Ms. Papalia earned her degrees at SUNY Plattsburgh and her CCRA certification from the Association of Clinical Research Professionals. She is an active member of the Massachusetts Medical Reserve Corp and a certified medical volunteer for the Boston Athletic Association.

RenalGuard has been developed to help prevent the onset of Contrast-Induced Nephropathy (CIN) in at-risk patients undergoing certain imaging procedures.  The RenalGuard System™ consists of a patented closed loop, software-controlled console and proprietary single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.

About PLC Systems Inc.

PLC Systems Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Headquartered in Franklin, Massachusetts, PLC today focuses on its newest product, RenalGuard, which is approved for sale in the EU as a general fluid balancing device. Additional company information can be found at www.plcmed.com.

This press release contains "forward-looking" statements. For this purpose, any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will" and similar expressions are intended to identify forward-looking statements. Our statements of our objectives are also forward-looking statements. While we may elect to update forward-looking statements in the future, we specifically disclaim any obligation to do so, even if our estimates change, and you should not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release. Actual results could differ materially from those indicated by such forward-looking statements as a result of a variety of important factors, including that we may not receive necessary regulatory approvals to market our RenalGuard product or that such approvals may be withdrawn, the current clinical trials in Italy and the planned future U.S. clinical trial for RenalGuard may not be completed in a timely fashion, if at all, or, if these clinical trials are completed, they may not produce clinically significant or meaningful results, the RenalGuard product may not be commercially accepted, operational changes, competitive developments may affect the market for our products, regulatory approval requirements may affect the market for our products, and additional risk factors described in the "Forward Looking Statements" section of our Annual Report on Form 10-K for the year ended December 31, 2010, a copy of which is filed with the SEC.

PLC Systems, PLC Medical Systems, PLC, RenalGuard and RenalGuard System are trademarks of PLC Systems Inc.

Contact:  Mary T. Conway
Conway Communications
508-520-2545
marytconway@comcast.net


'/>"/>
SOURCE PLC Systems Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Concord Medical Announces First Quarter 2011 Financial Results
2. NMT Medical, Inc. Adds Intellectual Property to Its Sealed Bid Sale of Friday, June 10, 2011 at Twelve OClock Noon
3. HASCO Medical Announces Acquisition of Mobility Freedom Inc. and Wheelchair Vans of America
4. Hackensack University Medical Center Employs Built-To-Last Automated Storage by Talyst
5. Reportlinker Adds Medical Devices Reports Bundle
6. Massachusetts Home Medical Equipment Providers Back Federal Legislation to Repeal Controversial Medicare Bidding Program
7. Maine Medical Equipment Providers Back Congressional Bill to Repeal Flawed Medicare Bidding Program
8. BridgePoint Medical Announced 510(k) Clearance for an Expanded Indication to Treat Coronary Chronic Total Occlusions
9. UBM Canon Medical Device Content Team Announces Upcoming Virtual Event Content Topics
10. FDA Formally Accepts Dune Medicals MarginProbeâ„¢ System Pre-Market Approval (PMA) Application and Grants Expedited Review Status
11. STMicroelectronics Reveals Best-in-Class Technology Enabling Longer-Lasting Broadcast and Medical-Imaging Equipment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... April 29, 2016 Glycotope GmbH, ... today announces the appointment of Dr. Alfredo Zurlo ... is an oncologist with many years clinical experience and ... industries. His last role was at Mologen AG where ... Executive Board. Previously Dr. Zurlo held various positions at ...
(Date:4/28/2016)... FLINT, Mich. , April 28, 2016 /PRNewswire/ ... transaction . Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... it has signed a definitive agreement to acquire ... Advanced Specialty Pharmacy ("TNH"), a leading specialty pharmacy ... Van Nuys, California . In 2015, ...
(Date:4/28/2016)... 28, 2016 Research and Markets ... Surgery Products Market 2016-2020" report to their offering. ... The global plastic surgery products market is ... the period 2016-2020. , ,The growing adoption of laser ... growth of the market. Lasers are used to treat ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... , ... The number of chronically and seriously ill individuals is growing. Americans ... urgent need for highly skilled care managers and care coordinators. Care Excellence ... and retain care managers, and enhance their skills. , Care Excellence helps ...
(Date:4/28/2016)... ... , ... Sublime Beauty® is offering a special deal on its webstore. , Buy 1 product ... applied to the product with lesser value. In addition, a free bonus of 3 ... in products. , "So many women (men, too) love our products and get good results. ...
(Date:4/28/2016)... ... 28, 2016 , ... La Sirena Foods provides premium canned seafood, specifically, Tuna, ... looking to grow their market share in the USA. , "We are happy to ... Sirena Foods and indirectly with Otis McAllister , a leading global food ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ... a new CDISC standard, Clinical Trial Registry (CTR) XML. Clinical trial registries ... will make it possible to build applications that generate submissions for multiple, ...
(Date:4/28/2016)... ... April 28, 2016 , ... Greener Hydroponics is now offering ... are frequently used by professional organic farmers and nurseries according to Sales Manager Joe ... of fabric pots. Our goal is to offer wholesale level pricing and ultra-fast shipping ...
Breaking Medicine News(10 mins):